ArrowMark Colorado Holdings’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-410,797
| Closed | -$19.1M | – | 333 |
|
2023
Q2 | $19.1M | Sell |
410,797
-1,412
| -0.3% | -$65.6K | 0.21% | 99 |
|
2023
Q1 | $11.8M | Sell |
412,209
-2,622
| -0.6% | -$75.1K | 0.13% | 127 |
|
2022
Q4 | $12.9M | Sell |
414,831
-216,302
| -34% | -$6.75M | 0.15% | 117 |
|
2022
Q3 | $12.8M | Buy |
631,133
+11,700
| +2% | +$237K | 0.16% | 122 |
|
2022
Q2 | $9.61M | Buy |
619,433
+170,599
| +38% | +$2.65M | 0.11% | 167 |
|
2022
Q1 | $8.59M | Buy |
448,834
+23,737
| +6% | +$454K | 0.08% | 205 |
|
2021
Q4 | $10.8M | Buy |
425,097
+14,664
| +4% | +$371K | 0.09% | 187 |
|
2021
Q3 | $13.4M | Buy |
+410,433
| New | +$13.4M | 0.11% | 163 |
|